Table 1 Patient characteristics
Total | Linac group | Tomotherapy group | |
|---|---|---|---|
n = 64 | n = 40 | n = 24 | |
Median age | 72 | 69 | 74 |
(range) | (53–84) | (55–79) | (53–84) |
D'Amico's risk classification | |||
Low | 14 | 6 | 8 |
Intermediate | 16 | 9 | 7 |
High | 34 | 25 | 9 |
Clinical T stage | |||
T1 | 22 | 12 | 10 |
T2 | 25 | 15 | 10 |
T3 | 17 | 13 | 4 |
Gleason sum score | |||
≤ 6 | 25 | 13 | 12 |
7 | 25 | 17 | 8 |
≥ 8 | 14 | 10 | 4 |
Initial PSA (ng/ml) | |||
< 10 | 31 | 18 | 13 |
10-20 | 18 | 10 | 8 |
> 20 | 15 | 12 | 3 |
Use of ADT | 48 | 32 | 16 |
Use of antithrombotics | 16 | 8 | 8 |
Presence of DM | 10 | 4 | 6 |